Related Experiment Video
Updated: Oct 29, 2025

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Ventricular non-compaction review
Shaurya Srivastava1, Majid Yavari2, Abdullah Al-Abcha2
1Department of Internal Medicine, Michigan State University, East Lansing, USA. srivas28@msu.edu.
Insights
Left ventricular non-compaction cardiomyopathy (LVNC) is a rare heart condition. This review covers its causes, diagnosis, and management, highlighting the need for standardized guidelines.
Area of Science:
- Cardiology
- Medical Diagnostics
- Genetics
Background:
- Left ventricular non-compaction cardiomyopathy (LVNC) is a rare, unclassified cardiomyopathy.
- It can lead to heart failure, arrhythmias, and embolic events in adults.
- Diagnostic criteria across echocardiography, CMR, and CT imaging are not standardized.
Purpose of the Study:
- To provide a comprehensive review of LVNC.
- To discuss etiologies, pathogenesis, and diagnostic criteria.
- To explore current management and treatment strategies, addressing data limitations.
Main Methods:
- Literature review of existing studies on LVNC.
- Analysis of diagnostic imaging modalities (echocardiography, CMR, CT).
- Review of current management practices and treatment debates.
Main Results:
- LVNC diagnosis lacks standardized criteria, complicating management.
- The condition presents in various forms, influencing treatment approaches.
- Evidence for definitive management guidelines regarding anticoagulation and arrhythmia prevention is limited.
Conclusions:
- LVNC requires further research to establish diagnostic standards.
- Standardized management guidelines are needed to improve patient outcomes.
- Comprehensive understanding of LVNC's diverse presentations is crucial for effective treatment.
Abstract:
Left ventricular non-compaction cardiomyopathy (LVNC) is a rare and unclassified cardiomyopathy that carries the potential to cause heart failure, arrhythmias, and embolic events within adults. The diagnosis of this cardiomyopathy can be based off a variety of echocardiographic, cardiac magnetic resonance (CMR), and computed tomography (CT) imaging criteria; none of which have been standardized to establish a firm diagnosis. This is further complicated by the observation from prior studies that LVNC may present as different forms of cardiomyopathy, each with its own subset of nuances that may change treatment strategies. Management of such cardiomyopathy has been debated in terms of anticoagulation, electrophysiologic studies to prevent arrhythmia, as well as heart failure prevention. Not enough data exists in regard to establishing firm guidelines for management. The following article aims to provide a comprehensive review in regard to the etiologies, pathogenesis, diagnostic criteria, management, and treatment of LVNC.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation I: Introduction
Aortic Regurgitation I: Introduction

